Abstract

In this contract, we plan to scale up the production of rhMFG-E8 using an E.coli system for the proposed experiments to assess rhMFG-E8S efficacy in a rat model of acute alcohol exposure and subsequent polymicrobial infection. Moreover, the improved scale-up will be used for future pre-clinical development.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Small Business Innovation Research – Phase I (N43)
Project #
275201200002C-0-0-1
Application #
8528954
Study Section
Project Start
2011-10-28
Project End
2012-07-31
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$200,000
Indirect Cost

  Institution

Name
Therasource, LLC
Department
Type
DUNS #
144994972
City
Roslyn
State
NY
Country
United States
Zip Code
11576